Test performance evaluation of SARS-CoV-2 serological assays
Open Access
- 29 April 2020
- preprint content
- other
- Published by Cold Spring Harbor Laboratory in medRxiv
Abstract
Background: Serological tests are crucial tools for assessments of SARS-CoV-2 exposure, infection and potential immunity. Their appropriate use and interpretation require accurate assay performance data. Method: We conducted an evaluation of 10 lateral flow assays (LFAs) and two ELISAs to detect anti-SARS-CoV-2 antibodies. The specimen set comprised 130 plasma or serum samples from 80 symptomatic SARS-CoV-2 RT-PCR-positive individuals; 108 pre-COVID-19 negative controls; and 52 recent samples from individuals who underwent respiratory viral testing but were not diagnosed with Coronavirus Disease 2019 (COVID-19). Samples were blinded and LFA results were interpreted by two independent readers, using a standardized intensity scoring system. Results: Among specimens from SARS-CoV-2 RT-PCR-positive individuals, the percent seropositive increased with time interval, peaking at 81.8-100.0% in samples taken >20 days after symptom onset. Test specificity ranged from 84.3-100.0% in pre-COVID-19 specimens. Specificity was higher when weak LFA bands were considered negative, but this decreased sensitivity. IgM detection was more variable than IgG, and detection was highest when IgM and IgG results were combined. Agreement between ELISAs and LFAs ranged from 75.8-94.8%. No consistent cross-reactivity was observed. Conclusion: Our evaluation showed heterogeneous assay performance. Reader training is key to reliable LFA performance, and can be tailored for survey goals. Informed use of serology will require evaluations covering the full spectrum of SARS-CoV-2 infections, from asymptomatic and mild infection to severe disease, and later convalescence. Well-designed studies to elucidate the mechanisms and serological correlates of protective immunity will be crucial to guide rational clinical and public health policies.Keywords
This publication has 15 references indexed in Scilit:
- Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020Emerging Infectious Diseases, 2020
- Presumed Asymptomatic Carrier Transmission of COVID-19JAMA, 2020
- Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020Mmwr-Morbidity and Mortality Weekly Report, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Viral Kinetics and Antibody Responses in Patients with COVID-19Published by Cold Spring Harbor Laboratory ,2020
- Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Temporal dynamics in viral shedding and transmissibility of COVID-19Published by Cold Spring Harbor Laboratory ,2020
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020Eurosurveillance, 2020
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19)Published by Cold Spring Harbor Laboratory ,2020
- Chagas disease serological test performance in United States blood donor specimensPublished by Cold Spring Harbor Laboratory ,2019